Novavax COVID-19 Vaccine Receives FDA EUA for Ages 12 to 17

Novavax

Novamax Inc. announced the U.S. Food and Drug Administration (FDA) granted its COVID-19 vaccine, NVX-CoV2373, emergency usage authorization (EUA) for youth ages 12 to 17 on Friday. Last month, the company received emergency approval for adults 18 and older. FDA Commissioner Robert M. Califf, M.D. said: “Authorizing an additional COVID-19 vaccine expands the available options […]

FDA Approves New COVID Vaccine

FDA

The Food and Drug Administration (FDA) has approved a new two-dose COVID vaccine called Novavax. This injection is based more on conventional protein technology used for decades in HPV and hepatitis B vaccines. The FDA authorized the new shots on July 13, 2022. When the COVID-19 pandemic struck in 2020, Novavx was one of the […]